Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026)

Phibro Animal Health (PAHC) recorded quarterly Other Non-Current Assets of $100.2 million in Q1 2026, up 2983.23% quarter-over-quarter from $3.2 million in Q4 2025, and up 493.17% on a YoY basis from $16.9 million in Q1 2025.

Phibro Animal Health (PAHC) Other Non-Current Assets (2013 - 2026) Analysis & Trends

Phibro Animal Health's Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $100.2 million for Q1 2026.

  • In Q1 2026, Other Non-Current Assets rose 493.17% year-over-year to $100.2 million; the TTM figure through Mar 2026 stood at $100.2 million (up 493.17% YoY), while the FY2025 annual figure was $99.5 million, up 1267.18% from the prior year.
  • Other Non-Current Assets was $100.2 million for Q1 2026 at Phibro Animal Health, up from $3.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $107.3 million in Q4 2024 to a low of $615000.0 in Q3 2025.
  • Historically, Other Non-Current Assets has averaged $27.5 million across 5 years, with a median of $6.6 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets sank 98.48% in 2023, then surged 4421.54% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $5.9 million in 2022, then sank by 60.01% to $2.4 million in 2023, then soared by 4421.54% to $107.3 million in 2024, then plunged by 96.97% to $3.2 million in 2025, then jumped by 2983.23% to $100.2 million in 2026.
  • The last three Other Non-Current Assets figures came in at $100.2 million (Q1 2026), $3.2 million (Q4 2025), and $615000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Phibro Animal Health 1.32 Bn 1.24 Bn 125.68 Mn 100.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 100.21 Mn
Dec 31, 2025 3.25 Mn
Sep 30, 2025 615,000.00
Jun 30, 2025 99.49 Mn
Mar 31, 2025 16.89 Mn
Dec 31, 2024 107.25 Mn
Sep 30, 2024 8.84 Mn
Jun 30, 2024 7.28 Mn
Mar 31, 2024 1.04 Mn
Dec 31, 2023 2.37 Mn
Sep 30, 2023 1.28 Mn
Jun 30, 2023 6.62 Mn
Mar 31, 2023 6.16 Mn
Dec 31, 2022 5.93 Mn
Sep 30, 2022 84.56 Mn
Jun 30, 2022 8.70 Mn
Mar 31, 2022 6.29 Mn
Dec 31, 2021 75.11 Mn
Sep 30, 2021 71.78 Mn
Jun 30, 2021 5.66 Mn